athira pharma stock forecast cnn

Is 337 for 2023 Jul. Athira Pharma stock monthly and weekly forecasts.


An Overview Of Today S Alzheimer S Disease Development Field Finnoexpert

Is 348 for 2026 Jul.

. Get an edge in the market with our Athira Pharma Inc. ATHA one year forecast. Not an offer or recommendation by Stocktwits.

In the short term 2weeks. During the last trading day the stock fluctuated 674 from a day. Stock forecast for tomorrow and next 5 days.

The 6 analysts offering price forecasts for Athira Pharma have a median target of 1600 with a high estimate of 3300 and a. ATHA share price prediction for 2022 2023 2024 2025 2026 and 2027. On average 2 Wall Street analysts forecast ATHAs earnings for 2022 to be -98704260 with the lowest ATHA earnings forecast at.

Is 407 and for 2031 Jul. The Score for ATHA is 75 which is 50 above its historic median. Get Athira Pharma Inc ATHANASDAQ real-time stock quotes news price and financial information from CNBC.

Atha a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal. Bothell wash july 25 2022 globe newswire -- athira pharma inc. Athira Pharma Inc stock price forecast for further price development up to 578 time horizon.

Athira Pharma s earnings in 2022 is -77328000. Stock falls 68 Shares of Athira Pharma Inc. ATHA IEX Real-Time Price USD 350.

ATHA Stock Price Prediction 600 10202 Upside Based on 2 Wall Street analysts offering 12 month price targets for Athira Pharma in the last 3 months. ATHA stock forecast Our latest prediction for Athira Pharma Incs stock price was made on the July 6 2022 when the stock price was at 339. The average price target is 600.

Athira says its Alzheimers treatment did not meet endpoint in mid-stage trial. Stock price fell by -139 on the last day Monday 24th Oct 2022 from 361 to 356. Athira Pharma Inc.

Get the latest ATHA stock forecast powered by the most important price indicators. 18 2020 at 1202 pm. The current Athira Pharma ATHA share price is 356.

According to 12 stock analysts the average 12. Athira Pharma Inc 336 007 213 Watch. ET by Tomi Kilgore Athira Pharmas stock indicated to open around 2200 or 29.

Forecast for 2022 Aug. Athira Pharma Inc NASDAQ Updated Oct. The Athira Pharma Inc.

Athira Pharma Inc. See Athira Pharma Inc. Stock Price Forecast The 6 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 2000 with a high estimate of 3500 and a low estimate of 1400.

ATHA stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Athira Pharma stocks first trade was at 1995 or 174 above the IPO price Sep. September 6 2022 Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimers Patients August 15 2022.

Athira Pharma Stock Forecast. 1 day and price target of 330 USD. Athira Pharma stock was originally listed at a price of 1711 in Sep 18 2020.

Is Athira Pharma Stock Undervalued. What are analysts forecasts for Athira Pharma stock. ATHA -174 tumbled 680 in premarket trading on.

Is 334 for 2027 Jul. If you had invested in Athira Pharma stock at 1711 your return over the last 2 years would have.


Rapid Micro And Athira Pharma Stock See Action From Activist Investors Barron S


Home


Atha Stock Price Forecast Should You Buy Atha


Athira Pharma Shares Drop Nearly 70 On Release Of Clinical Trial Data For Alzheimer S Disease Geekwire


Why Athira Pharma Stock Imploded Today Flipboard


Sec Filing Athira Pharma


F7vnxcsxbxmy2m


Atha Institutional Ownership And Shareholders Athira Pharma Inc Nasdaq Stock


Sec Filing Athira Pharma


70d9a30d 2a7d 4fd4 A93e 176e1621c9a3 Jpg


Atha Short Interest Athira Pharma Inc Stock Short Squeeze Borrow Rates


Athira Pharma Inc Proxy Soliciting Materials Dfan14a


An Overview Of Today S Alzheimer S Disease Development Field Finnoexpert


Kubsv Kubsv Twitter


What Is The Ownership Structure Like For Athira Pharma Inc Nasdaq Atha Nasdaq


Athira Pharma Shares Drop Nearly 70 On Release Of Clinical Trial Data For Alzheimer S Disease Geekwire


An Overview Of Today S Alzheimer S Disease Development Field Finnoexpert


Latest Drama At Athira Investor Calls For Ceo Replacement And Wants Two Board Seats Geekwire


Athira Pharma Inc Atha Stock Price Quote News Stock Analysis

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel